Despite that the prevalence of depression has been thoroughly analyzed in multiple sclerosis (MS) patients and affects approximately 15%-20% of the MS population, attention paid to social activities concomitant with anxiety is still too sporadic. The aim of this study was to find the prevalence of anxiety and social activities aggraded/aggravated with anxiety in the MS population in Lithuania and to analyze how it correlates with socio-demographic factors, clinical outcomes of MS and depression. Three hundred twelve MS patients took part in this study; anxiety prevalence was pointed in 20.2%. Only 23.4% of the study population was socially active. Our study shows a significant level of anxiety and low level of social activity in people with MS. Anxiety in MS patients was strongly related with younger age, shorter MS duration, prevalence of depression and lower level of social activity. A higher level of social activity was significantly related with older urban MS patients who indicated family status as living together and longer MS duration.
Introduction
Multiple sclerosis (MS) is the most common disabling neurological illness among young people; the prevalence is about twice as high in women as in men. Early in the course the disease, the outcome is difficult to predict, although some prognostic factors are known [1] . After 15 to 20 years of disease duration, 10%-20% of the patients have a good outcome [2, 3] . Living with a chronic disease with an unpredictable outcome may cause anxiety, depression and serious impairment in social activities. Despite that the prevalence of depression has been thoroughly investigated in MS patients and involves approximately 15%-20% [4] [5] [6] [7] , attention paid to the correlation of level of social activity with anxiety remains sporadic. The social, personal and financial costs of anxiety disorders in the general population are considerable [8] [9] [10] . Preliminary data from a single MS study suggests a similar picture, with anxiety linked to more somatic complaints, greater social dysfunction and increased thoughts of suicide [11] . This underscores the importance of gaining a better understanding of anxiety disorders in MS, for an overlooked diagnosis represents a missed chance at reducing the morbidity associated with this disabling disease. Unfortunately, clinical manifestations of anxiety and social activity level correlated with anxiety are not routinely and systematically evaluated in MS patients. The aim of this study was to examine the prevalence of anxiety and level of social activity correlated with anxiety in the MS population in Lithuania and to analyze how that correlates with socio-demographic factors, clinical outcomes of MS and depression.
Materials and methods
The study included 312 patients with a positive diagnosis of MS by a neurologist; this was part of a previously published study regarding prevalence of depression in MS patients in Lithuania. Leonavičius Table 1 .
The socio-demographic and clinical characteristics were adjusted on the basis of medical history: their education, family status, residence, clinical subtype of MS, and use of immunomodulators (IM). Occurrence of depression was based on the ICD-10 classification. These characteristics were similar in the female and male groups (p>0.05) ( Table 2) .
Symptoms of anxiety were measured using the Hospital Anxiety and Depression Scale (HADS) [13] . This self-rating questionnaire contains seven questions that focus on symptoms of anxiety (HADS-A) and seven questions that address depressive symptoms (HADS-D). The HADS questionnaire asks specifically about symptoms that appeared during the last week prior to answering the questionnaire [14] .
For the past 7 years, all MS patients in Lithuania have been invited to take an active part in social MS group activities. Therefore, patients were asked to answer the question about their MS association activities: 'Did you take an active part during the last year in MS group activities such as clubs, meetings, camps, trainings, self-help groups, or other projects?'
Statistics
The data analysis was performed at Information Tech- 
Results
Anxiety was reported in 20.2%, and participation in social activity in 23.4% of MS patients. In neither case was there a large difference between females and males (Table 3) .
Multifactor logistic regression showed that the effect of being a MS patient with anxiety was strongly related with younger age, shorter MS duration, fewer MS group activities, and prevalence of depression. However, such characteristics as gender, education, family status, residence, clinical subtype of MS, use of IM, and EDSS score did not show any significant relation with anxiety (p>0.05) ( Table 4) .
To determine the independent socio-demographic and clinical factors associated with MS group activities, multifactor logistic regression was used. The dependent factor was 'MS social activity present/absent' (0/1).
The series of independent factors included gender, age, education, family status, residence, clinical subtype of MS, duration of MS, EDSS score, treatment with IM, and prevalence of depression and anxiety (Table 5) .
MS group activity among MS patients was strongly correlated with older age, family status noted as living together, urban residence and longer MS duration. Independent factors as gender, education, clinical subtype of MS, EDSS score, treatment with IM, prevalence of depression and anxiety were not correlated with MS patients who answered that they were socially active (p>0.05).
Discussion
The present study shows that persons with MS report symptoms of anxiety (20.2%) in a statistically significantly higher proportion than that in the normal population; these results are in line with other publications, for instance: Beiske, 19.3% [15] ; Korostil, 18.6% [16] ; Kehler, 25.0% [17] ; and Dahl, 30.2% [18] . However, the prevalence of anxiety and its relation to socio-demographic and clinical characteristics of the MS patient population is much less thoroughly investigated than prevalence of depression in the general population and needs much more attention from scientists [19] .
In our study, females with MS reported slightly more symptoms of anxiety than did males (22 There are few robust epidemiological studies addressing anxiety in MS using standardized and validated outcome measures. In addition to their own results, Nicholl et al. reviewed past research on emotional problems in people who have MS. The most striking features in studies covered by that review, which treated 15 studies published from 1980 to 2000, are the small sample sizes and the inherent selection bias. In their own study, the authors classified the patients into two categories: those who may be in need of intervention (cases) and those who were not in need of intervention. They found that 39% were case level on HADS-A with a cut-off value of 7 to 8. With a cut-off value of 10 to 11 on HADS-A, the percentage of case-level MS patients fell to 18 [20] . In a British study using the HADS, 34% of MS patients were case level for anxiety on HADS-A when standard cut-off levels were applied [21] .
In two Dutch studies using the HADS-A as the outcome measure, the authors concluded that MS patients suffer a substantial emotional burden from the disease. Eight months after diagnosis of MS, 34% of the patients reported that they experienced high levels of anxiety. In a follow-up study two years later, 69% of persons with MS with high anxiety scores at baseline still had high scores [22, 23] .
In a Canadian study using both the Structured Clinical Interview for DSM-IV disorders (SCID-IV) and the HADS self-report instrument, the authors concluded that anxiety disorders are common but frequently overlooked and under-treated in persons with MS. The lifetime prevalence of anxiety disorders was 35.7%, and in the Canadian study, 20.7% of the people with MS had clinically relevant self-reported anxiety [24] . In a recent Norwegian study using the Hopkins Symptom Checklist-25 (HSCL-25), 19.3% of the MS patients reported anxiety. A univariate analysis showed that anxiety was associated with fatigue, pain, younger age at onset and lower disability (EDSS <3). After the multiple regression analysis, however, lower disability lost significance, but fatigue, pain and younger age at onset remained significantly associated with anxiety. Thus, our results agree with published figures and corroborate previous studies showing a high occurrence of anxiety symptoms in persons with MS [25] . The bio-psycho-social model of psychiatric disorders reminds us that not only biological and psychological factors, but also social factors, can play an important role in disease presentation,. On the other hand, improvement of social activity could be very important for coping with disease symptoms. However, we find a gap in the literature when reviewing the new surveys in this area (especially as relevant for MS).
A substantial proportion of the persons with MS in our study reported a lack of personal social activities. Only 23.4% of participants noted that they take active part in MS goup activities like clubs, meetings, camps, trainings, self-help groups, and other projects. We found no association between the reporting of social activities and education, clinical subtype of MS, disability (EDSS), and treatment with IM, prevalence of depression and anxiety. There were statistically significant relations between patients who reported being social active and older age, family status noted as living together, urban residence and longer MS duration.
Skerrett et al. analyzed the role of patients' behavioral responses to their MS symptoms and social impairment. These authors concluded that the degree of neurological deficit was not associated with either physical or mental fatigue, although it was associated with social impairment. Depression, anxiety, and remission status were also related to fatigue and depression to social impairment [26] . To evaluate the changes in social experience and social needs that may occur with aging with MS, Fong et al. analyzed the perspective of older MS patients. That study provided an insider's view of the social changes that older adults through living with MS. The study identified barriers to the acquisition of support and addressed the importance of appropriately responding to the changing needs of this population [27] .
Einarsson et al. have analyzed the social activities of MS patients in Stockholm County, Sweden. The study included 166 people with MS; two-thirds indicated impairment in social activities, which is in line with our study [28] . Most affected were items that could be classified as mobility-related and physically demanding, underlining the importance of developing and using evidence-based exercise treatments and rehabilitation to increase independence in persons with MS. The association between psychosocial factors and pain intensity in MS patients was analyzed by Osborne et al.; these authors concluded that social support may be important for adjustment to pain in persons with MS [29] .
J. Halper analyzed the impact of relapses on the psychosocial condition of MS patients. Historically, the disease course of MS has been generally characterized by steady progression, with unpredictable relapses that sometimes end in remission. There has always been the threat of incomplete recovery during this period. Therefore, each relapse is a powerful reminder of the chronic nature of the disease, with a profound effect on the social sphere of the individual with MS. MS in general, and relapses in particular, strain the coping mechanisms of the individual and his or her family, friends, and vocational network. Recent evidence has shown that disease-modifying therapy reduces the frequency and severity of MS relapses, an important goal of MS management. Nevertheless, it is important for clinicians to be familiar with the widespread psychosocial impact of MS in terms of their patients' social involvement, partnership and family roles, and employment [30] . The results of our study showed some differences from Halper's study, concluding that social activities were not related with subtype (either relapsing-remitting, or progressive) of disease. Surprisingly, patients who suffered longer from MS indicated a higher level of social activity.
Janssens et al. provided results of impact on recently diagnosed MS on quality of life, anxiety, depression and distress of patients and partners. 34% of the patients and 40% of the partners had clinically high levels of anxiety, and 36% of the patients and 24% of the partners had levels of severe distress. Scores of anxiety, depression and distress were higher in patients with more functional limitations as measured by the EDSS. Quality of life was significantly worse in patients compared with controls, particularly among those with greater disability. Both patients and their partners demonstrated high levels of anxiety and distress in the early period after the diagnosis. These findings indicate that close attention should be paid by health care professionals to identify those who may benefit from further psychological support [31] .
Symptoms of anxiety in MS cause significant suffering and add to the existing disability. Our study shows that one of five persons with MS experiences significant anxiety symptoms; it is important to detect and treat these patients.
In conclusion, our study shows significant levels of anxiety and low levels of social activity in people with MS. Anxiety in MS patients was strongly related to younger age, shorter MS duration, prevalence of depression and lower social activities. A higher level of social activity was significantly related with older urban MS patients who indicated family status as living together and longer MS duration. However, follow-up studies would be requested to investigate influence of social activities on treatment of anxiety in MS patients.
